Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials

2022130 citationsJournal Articlehybrid Open Access

Authors

NCT02446912, NCT02446899.

Good health and well-being

Published in: Annals of the Rheumatic Diseases

Volume 81, Issue 7, pp. 951-961

Field-Weighted Citation Impact: 20.60